Changing factors associated with parent activation after pediatric hematopoietic stem cell transplant

Brian W Pennarola1, Angie Mae Rodday, Kristin Bingen

  • 1The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA, bwpennarola@gmail.com.

Insights

Parent activation in pediatric hematopoietic stem cell transplant (HSCT) is influenced by factors that change over time. Understanding these dynamics is crucial for supporting parents during and after HSCT.

Area of Science:

  • Pediatric Hematology
  • Oncology Nursing
  • Psychosocial Oncology

Background:

  • Pediatric hematopoietic stem cell transplant (HSCT) is a complex treatment with significant psychosocial implications for families.
  • Parental activation, defined as the ability to manage one's own health, is critical for navigating the challenges of pediatric HSCT.
  • Identifying factors influencing parent activation is essential for developing targeted support strategies.

Purpose of the Study:

  • To identify factors associated with parent activation in parents of children undergoing HSCT within six months post-transplant.
  • To determine if the association of these factors with parent activation changes over time.

Main Methods:

  • A cohort of 198 parents completed the Parent-Patient Activation Measure (Parent-PAM) before HSCT and at six months post-HSCT.
  • Clinical data and demographic information were collected.
  • A repeated measures model analyzed the association between factors and Parent-PAM scores, including time interactions.

Main Results:

  • Older parental age and never being married were associated with lower and higher Parent-PAM scores, respectively.
  • Parental emotional functioning became significant at six months post-HSCT, while the effect of illness duration diminished.
  • A shift from private to public insurance was linked to a drop in parent activation.

Conclusions:

  • Factors influencing parent activation evolve significantly in the first six months after pediatric HSCT.
  • These changes may reflect the cumulative emotional and financial burden of the transplant process on parents.
  • Findings underscore the need for ongoing psychosocial support tailored to parents' changing needs during and after HSCT.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.5K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
605
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
9.2K